Búsqueda | Biblioteca Virtual en Salud

1.

The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer.

Eustace, A J; Madden, S F; Fay, J; Collins, D M; Kay, E W; Sheehan, K M; Furney, S; Moran, B; Fagan, A; Morris, P G; Teiserskiene, A; Hill, A D; Grogan, L; Walshe, J M; Breathnach, O; Power, C; Duke, D; Egan, K; Gallagher, W M; O'Donovan, N; Crown, J; Toomey, S; Hennessy, B T.

Breast Cancer Res Treat ; 187(3): 635-645, 2021 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-33983492

2.

Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland.

McSorley, L M; Tharmabala, M; Al Rahbi, F; McSorley, K; Chew, S; Evoy, D; Geraghty, J G; Prichard, R S; Rothwell, J; McCartan, D P; McDermott, E W; Keane, M; Kennedy, M J; O'Reilly, S; Millen, S J; Crown, J P; Smyth, L M; Kelly, C M; Quinn, C M; Walshe, J M.

Breast Cancer Res Treat ; 188(3): 789-798, 2021 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-33835293

3.

Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up.

Murtagh, G; Lyons, T; O'Connell, E; Ballot, J; Geraghty, L; Fennelly, D; Gullo, G; Ledwidge, M; Crown, J; Gallagher, J; Watson, C; McDonald, K M; Walshe, J M.

Breast Cancer Res Treat ; 156(3): 501-506, 2016 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-27060913

4.

Invasive lobular carcinoma of the breast; clinicopathologic profile and response to neoadjuvant chemotherapy over a 15-year period.

Quirke, N P; Cullinane, C; Turk, M A; Shafique, N; Evoy, D; Geraghty, J; McCartan, D; Quinn, C; Walshe, J M; McDermott, E; Rutherford, C; Prichard, R S.

Breast ; 76: 103739, 2024 May 01.

Artículo en Inglés | MEDLINE | ID: mdl-38754140

5.

The Wilson disease gene: spectrum of mutations and their consequences.

Thomas, G R; Forbes, J R; Roberts, E A; Walshe, J M; Cox, D W.

Nat Genet ; 9(2): 210-7, 1995 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-7626145

6.

Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial.

de Azambuja, E; Agostinetto, E; Procter, M; Eiger, D; Pondé, N; Guillaume, S; Parlier, D; Lambertini, M; Desmet, A; Caballero, C; Aguila, C; Jerusalem, G; Walshe, J M; Frank, E; Bines, J; Loibl, S; Piccart-Gebhart, M; Ewer, M S; Dent, S; Plummer, C; Suter, T.

ESMO Open ; 8(1): 100772, 2023 02.

Artículo en Inglés | MEDLINE | ID: mdl-36681013

7.

Twenty-four novel mutations in Wilson disease patients of predominantly European ancestry.

Cox, D W; Prat, L; Walshe, J M; Heathcote, J; Gaffney, D.

Hum Mutat ; 26(3): 280, 2005 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-16088907

8.

The conquest of Wilson's disease.

Walshe, J M.

Brain ; 132(Pt 8): 2289-95, 2009 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-19596747

9.

Not Wilson's disease: a review of misdiagnosed cases.

Walshe, J M; Yealland, M.

QJM ; 88(1): 55-9, 1995 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-7894989

10.

Abdominal malignancies in patients with Wilson's disease.

Walshe, J M; Waldenström, E; Sams, V; Nordlinder, H; Westermark, K.

QJM ; 96(9): 657-62, 2003 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-12925721

11.

Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.

Walshe, J M.

Ann Clin Biochem ; 40(Pt 2): 115-21, 2003 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-12662398

12.

The discovery of the therapeutic use of D-penicillamine.

Walshe, J M.

J Rheumatol Suppl ; 7: 3-8, 1981.

Artículo en Inglés | MEDLINE | ID: mdl-7014875

13.

Penicillamine and the SLE syndrome.

Walshe, J M.

J Rheumatol Suppl ; 7: 155-60, 1981.

Artículo en Inglés | MEDLINE | ID: mdl-6939878

14.

Wilson's disease.

Walshe, J M.

Lancet ; 369(9565): 902, 2007 Mar 17.

Artículo en Inglés | MEDLINE | ID: mdl-17368141

15.

The acute haemolytic syndrome in Wilson's disease--a review of 22 patients.

Walshe, J M.

QJM ; 106(11): 1003-8, 2013 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-23842488

16.

Serum 'free' copper in Wilson disease.

Walshe, J M.

QJM ; 105(5): 419-23, 2012 May.

Artículo en Inglés | MEDLINE | ID: mdl-22139498

17.

Treatment of hepatic encephalopathy.

Walshe, J M.

Lancet ; 365(9468): 1385; author reply 1385-6, 2005.

Artículo en Inglés | MEDLINE | ID: mdl-15836881

18.

Management of rare diseases.

Walshe, J M.

QJM ; 99(2): 123-4, 2006 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-16428334

19.

The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.

Walshe, J M.

QJM ; 104(9): 775-8, 2011 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-21622540

20.

Wilson disease: a most unusual patient.

Walshe, J M.

QJM ; 109(2): 117-8, 2016 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-26286547

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer.

Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland.

Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up.

Invasive lobular carcinoma of the breast; clinicopathologic profile and response to neoadjuvant chemotherapy over a 15-year period.

The Wilson disease gene: spectrum of mutations and their consequences.

Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial.

Twenty-four novel mutations in Wilson disease patients of predominantly European ancestry.

The conquest of Wilson's disease.

Not Wilson's disease: a review of misdiagnosed cases.

Abdominal malignancies in patients with Wilson's disease.

Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.

The discovery of the therapeutic use of D-penicillamine.

Penicillamine and the SLE syndrome.

Wilson's disease.

The acute haemolytic syndrome in Wilson's disease--a review of 22 patients.

Serum 'free' copper in Wilson disease.

Treatment of hepatic encephalopathy.

Management of rare diseases.

The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.

Wilson disease: a most unusual patient.